EL
Estee Lauder Companies IncPrice & Indicators
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted effective tax rate non-GAAP | 31.8% | Q3 FY2026 | — |
| Free Cash Flow | $891M | Nine months ended March 31, 2026 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Household & Personal Products — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
EL
this stock
Estee Lauder Companies Inc
|
$29.91B | -20.8% | -8.2% | — | 2.2% |
|
PG
PROCTER & GAMBLE Co
|
$342.40B | +3.3% | +0.3% | 21.5 | 1.0% |
|
UL
Unilever PLC
|
$132.90B | -4.0% | — | — | 0.1% |
|
CL
Colgate Palmolive Co
|
$73.81B | +17.4% | +1.7% | 35.8 | 2.2% |
|
KVUE
Kenvue Inc.
|
$37.40B | +14.2% | -2.1% | 23.2 | 3.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| EL | -1.3% | -3.2% | -28.3% | +4.7% | -20.8% |
| SPY | +1.4% | +4.1% | +9.1% | +1.1% | +10.7% |
| vs SPY | -2.6% | -7.3% | -37.4% | +3.6% | -31.5% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.